Plastics of the left ventricle aneurysm with minimally invasive multivessel coronary artery bypass grafting by V.M. Demianenko, O.D. Babliak, D.Ye. Babliak, O.S. Stohov, E.A. Melnyk, K.A. Revenko, L.V. Pidgayna

“…This makes possible to broaden the horizons of minimally invasive multivessel coronary artery bypass grafting usage in complications of the myocardial infarction.…”
Get full text

Identifying etiologies of heart failure using non-contrast cardiac magnetic resonance imaging: cine imaging, T1 and T2 mapping, and texture analysis for T1 mapping by Yasuo Amano, Yasuyuki Suzuki, Xiaoyan Tang, Chisato Ando

“…We used Kruscal-Wallis’ with a post-hoc Steel-Dwass' test, Wilcoxon signed-ranked test, Pearson's chai square test and receiver operator curve analysis (ROC) to assess the usefulness of non-contrast CMR for identifying etiologies of HF.ResultsThere were significant differences in left ventricular end-diastolic volume (LVEDV) indexed to body surface area (LVEDVi), left ventricular myocardial mass/LVEDV, native T1, and vGLNU between dilated cardiomyopathy (DCM), hypertensive cardiomyopathy (HC) and tachycardia-induced cardiomyopathies (TIC). …”
Get full text

Incidence and Predictors of Outcome in the Treatment of In-Stent Restenosis with Drug-Eluting Balloons, a Real-Life Single-Centre Study by Kyle Murnaghan, Helen Bishop, Navjot Sandila, Bakhtiar Kidwai, Lawrence Title, Ata Ur Rehman Quraishi, Catherine Kells, Hussein Beydoun, Osama Elkhateeb

“…To determine the one-year and five-year occurrence and prognosticators of major adverse cardiac events (MACE: composition of all-cause death, myocardial infarction, target vessel revascularization, and vessel thrombosis), mortality, and target lesion revascularization (TLR) in patients with in-stent restenosis (ISR) treated with drug-eluting balloons (DEBs). …”
Get full text

Downregulation of CD4+LAP+ and CD4+CD25+ Regulatory T Cells in Acute Coronary Syndromes by Ying-zhong Lin, Shan-he Lu, Zheng-de Lu, Ying Huang, Ying Shi, Ling Liu, Xiao-yan Wang, Qing-wei Ji

“…Regulatory T (Treg) cells play a protective role in atherosclerosis prone models and are related to the onset of acute coronary syndromes (ACS, including non-ST-elevation ACS (NSTEACS) and ST-elevation acute myocardial infarction (STEAMI)). CD4+LAP+ Treg cells are a novel subset of Tregs that have been found to ameliorate atherosclerosis in ApoE-/- mice, and these cells also exist in humans. …”
Get full text

Malignant Course of Anomalous Left Coronary Artery Causing Sudden Cardiac Arrest: A Case Report and Review of the Literature by Mahesh Anantha Narayanan, Christopher DeZorzi, Abhilash Akinapelli, Toufik Mahfood Haddad, Aiman Smer, Janani Baskaran, William P. Biddle

“…Sudden cardiac arrest secondary to congenital anomalous coronary artery disease is characterized by insufficient coronary flow by the anomalous left coronary artery to meet elevated left ventricular (LV) myocardial demand. High risk defects include those involved with the proximal coronary artery or coursing of the anomalous artery between the aorta and pulmonary trunk. …”
Get full text

A new perspective on cardiovascular function and dysfunction during endurance exercise: identifying the primary cause of cardiovascular risk by Amine Souissi, Ismail Dergaa, Samia Ernez Hajri, Karim Chamari, Helmi Ben Saad

“…Importantly, we clearly revealed for the first time that endothelial damage, vasoconstriction, and blood coagulation (inducing thrombosis) are potentially the primary factors of cardiovascular dysfunction and myocardial infarction during and/or following endurance exercise.…”
Get full text

Successful Percutaneous Coronary Intervention for Atherosclerotic Coronary Lesion with Anomalous Origin of the Right Coronary Artery by Junji Matsuda, Takashi Ikenouchi, Giichi Nitta, Shunichi Kato, Kazuya Murata, Miki Kanoh, Yukihiro Inamura, Nobutaka Kato, Tomomasa Takamiya, Ken Negi, Akira Sato, Tsunehiro Yamato, Yutaka Matsumura, Junichi Nitta

“…Congenital coronary artery anomalies, including anomalous origin of a coronary artery, can manifest as life-threatening conditions, such as myocardial infarction or arrhythmia, and may even lead to sudden death associated with specific congenital anatomical features. …”
Get full text

Impact of Visit-to-Visit Triglyceride-Glucose Index Variability on the Risk of Cardiovascular Disease in the Elderly by Fei Chen, Ying Pan, Ziqing Liu, Rong Huang, Jing Wang, Jian Shao, Yaqin Gong, Xiyi Sun, Xiaobo Jiang, Weihao Wang, Zhaoqiang Li, Shao Zhong, Qi Pan, Kaixin Zhou

“…CVD events were identified from the chronic disease registry or follow-up database and included myocardial infarction, angina, coronary, and stroke. …”
Get full text

Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents by L. Testa, G. G. L. Biondi Zoccai, M. Valgimigli, R. A. Latini, S. Pizzocri, S. Lanotte, M. L. Laudisa, N. Brambilla, M. R. Ward, G. A. Figtree, F. Bedogni, R. Bhindi

“…They significantly reduce platelet activity and are therefore clinically beneficial in settings where platelet activation is a key pathophysiological feature, particularly myocardial infarction. Ticlopidine, the first of the class introduced to clinical practice, was soon challenged and almost completely replaced by clopidogrel for its better tolerability. …”
Get full text

Cardiac events and procedures following COVID-19 compared with other pneumonias: a national register study by Knut Stavem, Peder Langeland Myhre, Kristian Berge, Tarjei Øvrebotten, Birgitte Tholin

“…We defined outcomes using ICD-10 codes for incident myocarditis, acute myocardial infarction, atrial fibrillation/flutter, heart failure, ischaemic heart disease, other cardiac disease and total cardiac disease (any heart condition). …”
Get full text

Treatment of Aortic and Iliac Artery Aneurysms with Multilayer Flow Modulator: Single Centre Experiences by Cengiz Ovalı, Aykut Şahin, Murat Eroğlu, Sinan Balçın, Sadettin Dernek, Mustafa Behçet Sevin

“…The third patient died at the end of the third month due to acute myocardial infarction. The rest of the patients developed no complications or had no mortality at their 12-month follow-ups. …”
Get full text

The first clinical case of the left-ventricular electrode implantation with active fixation for the purpose of cardiac resynchronization therapy in Ukraine by V.V. Boiko, S.V. Rybchynskyi, D.O. Lopin, D.E. Volkov

“…Chronic heart failure is one of the most prevalent problems of cardiology due to the increasing number of cases of coronary heart disease, non-coronary myocardial damage and increased life expectancy of the population. …”
Get full text

Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis by Chun Shing Kwok, Heerajnarain Bulluck, Alisdair D. Ryding, Yoon K. Loke

“…No significant increase in the composite endpoint of death and nonfatal myocardial infarction was observed with earlier cessation of DAPT in any instance when compared to longer durations of DAPT (RR 0.64 95% CI 0.25–1.63 for 3 versus 12 months, RR 1.09 95% CI 0.84–1.41 for 6 versus 12 months and, RR 0.64 95% CI 0.35–1.16 for 12 versus 24 months). …”
Get full text

Comparison of Preoperative Assessment of Patient’s Metabolic Equivalents (METs) Estimated from History versus Measured by Exercise Cardiac Stress Testing by Adam S. Weinstein, Martin I. Sigurdsson, Angela M. Bader

“…This is typically done by inquiring about the patient’s physical activity, with the goal of providing an estimate of the metabolic equivalents (METs) that the patient can perform without signs of myocardial ischemia or cardiac failure. We sought to compare estimates of patients’ METs between preoperative assessment by medical history with quantified assessment of METs via the exercise cardiac stress test. …”
Get full text

Outcomes of Percutaneous Coronary Intervention in Patients with Spontaneous Coronary Artery Dissection by Saber Hassan, Rohit Samuel, Andrew Starovoytov, Carolyn Lee, Eve Aymong, Jacqueline Saw

“…SCAD is an important cause of myocardial infarction (MI) in young-to-middle-aged women. …”
Get full text

Study of Erythrocyte Indices, Erythrocyte Morphometric Indicators, and Oxygen-Binding Properties of Hemoglobin Hematoporphyrin Patients with Cardiovascular Diseases by Victor V. Revin, Antonina A. Ushakova, Natalia V. Gromova, Larisa A. Balykova, Elvira S. Revina, Vera V. Stolyarova, Tatiana A. Stolbova, Ilya N. Solomadin, Alexander Yu. Tychkov, Nadezhda V. Revina, Oksana G. Imarova

“…The current study investigates the functional state of erythrocytes and indices of the oxygen-binding capacity of hemoglobin in blood samples from healthy donors and from patients with coronary artery disease and myocardial infarction before and after treatment. It has been established that, in cardiovascular diseases, erythrocyte morphology and hemoglobin oxygen-transporting disorders are observed. …”
Get full text

Cardiovascular Outcomes in Patients on Hemodialysis following Drug-Eluting versus Bare-Metal Coronary Stents by Amir F. Mohani, Srikanth Penumetsa, Amin Daoulah, Gregory Giugliano, Amir Lotfi

“…The primary outcome compared was a composite of all-cause death, myocardial infarction (MI), congestive heart failure (CHF), target vessel revascularization (TVR), and stroke at 30 days and one year. …”
Get full text

Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses by Xiaowen Shi, Bin Zhang, Zhenliang Chu, Bingjiang Han, Xueping Zhang, Ping Huang, Jibo Han

“…The indices related to myocardial hypertrophy and oxidative stress were detected. …”
Get full text

Impact of Percutaneous Coronary Intervention and Implantation of Intra-Aortic Balloon Pump on the Outcome of an Acute Total Obstruction of the Left Main Coronary Artery by Hamza Hamayel, Yahya Ismail, Sajed Majadla, Yousef Hamshari, Yunis Daralammouri

“…An electrocardiogram showed anterior ST-elevation myocardial infarction. He was given loading doses of dual antiplatelet agents, in addition to respiratory support, then transferred immediately to the cardiac catheterization laboratory. …”
Get full text

Cerebrovascular stenosis related to tyrosine kinase inhibitor for chronic myeloid leukemia: two illustrative cases by Nozomi Sasaki, Yukiko Enomoto, Takamitsu Hori, Hirofumi Matsubara, Yusuke Egashira, Tsuyoshi Izumo

“…Nilotinib and ponatinib, second- and third-generation TKIs, respectively, have been reported to cause adverse vascular occlusive events such as myocardial infarction and peripheral arterial disease. …”
Get full text